Neos Therapeutics to Present at Jefferies 2017 Global Healthcare Conference
May 30, 2017 11:34 am UTC| Business
DALLAS and FORT WORTH, Texas, May 30, 2017 -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) products using its...
Kura Oncology to Participate in Two Upcoming Investor Conferences
May 30, 2017 11:33 am UTC| Business
LA JOLLA, Calif., May 30, 2017 -- Kura Oncology, Inc. (NASDAQ:KURA), a clinical stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced that Troy Wilson, Ph.D.,...
Kura Oncology to Participate in Two Upcoming Investor Conferences
May 30, 2017 11:33 am UTC| Business
LA JOLLA, Calif., May 30, 2017 -- Kura Oncology, Inc. (NASDAQ:KURA), a clinical stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced that Troy Wilson, Ph.D.,...
Kura Oncology to Participate in Two Upcoming Investor Conferences
May 30, 2017 11:33 am UTC| Business
LA JOLLA, Calif., May 30, 2017 -- Kura Oncology, Inc. (NASDAQ:KURA), a clinical stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced that Troy Wilson, Ph.D.,...
Kura Oncology to Participate in Two Upcoming Investor Conferences
May 30, 2017 11:33 am UTC| Business
LA JOLLA, Calif., May 30, 2017 -- Kura Oncology, Inc. (NASDAQ:KURA), a clinical stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced that Troy Wilson, Ph.D.,...
May 30, 2017 11:32 am UTC| Business
BEVERLY, Mass., May 30, 2017 -- Cellceutix Corporation, (OTCQB:CTIX) (“the Company”), is pleased to share further data supporting the p53 mechanism of action of Kevetrin and its treatment potential in Acute Myeloid...
May 30, 2017 11:32 am UTC| Business
BEVERLY, Mass., May 30, 2017 -- Cellceutix Corporation, (OTCQB:CTIX) (“the Company”), is pleased to share further data supporting the p53 mechanism of action of Kevetrin and its treatment potential in Acute Myeloid...